Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients with rheumatoid arthritis (RA) refractory to disease- modifying antirheumatic drugs (DMARDs) (1-4). At about the same time as the European approval of the third anti-TNFα agent (adalimumab) for treati...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-09-01
|
| Series: | Reumatismo |
| Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/403 |
| _version_ | 1811292066184953856 |
|---|---|
| author | R. Caporali M. Filippini R. Gorla E.G. Favalli A. Marchesoni M. Antivalle P. Sarzi- Puttini F. Bobbio-Pallavicini C. Montecucco F. Atzeni |
| author_facet | R. Caporali M. Filippini R. Gorla E.G. Favalli A. Marchesoni M. Antivalle P. Sarzi- Puttini F. Bobbio-Pallavicini C. Montecucco F. Atzeni |
| author_sort | R. Caporali |
| collection | DOAJ |
| description | Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients with rheumatoid arthritis (RA) refractory to disease- modifying antirheumatic drugs (DMARDs) (1-4). At about the same time as the European approval of the third anti-TNFα agent (adalimumab) for treating RA patients, the Italian Society of Rheumatology (Società Italiana di Reumatologia [SIR]) started a database for the registration and active follow-up of RA patients treated with biological response modifiers, which contains all of the demographic and clinical parameters, as well as the therapeutic data, usually needed to follow RA patients... |
| first_indexed | 2024-04-13T04:39:51Z |
| format | Article |
| id | doaj.art-a3e6e4291560442c8293fdb98392bc26 |
| institution | Directory Open Access Journal |
| issn | 0048-7449 2240-2683 |
| language | English |
| last_indexed | 2024-04-13T04:39:51Z |
| publishDate | 2011-09-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Reumatismo |
| spelling | doaj.art-a3e6e4291560442c8293fdb98392bc262022-12-22T03:02:03ZengPAGEPress PublicationsReumatismo0048-74492240-26832011-09-0160429029510.4081/reumatismo.2008.290Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)R. CaporaliM. FilippiniR. GorlaE.G. FavalliA. MarchesoniM. AntivalleP. Sarzi- PuttiniF. Bobbio-PallaviciniC. MontecuccoF. AtzeniClinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients with rheumatoid arthritis (RA) refractory to disease- modifying antirheumatic drugs (DMARDs) (1-4). At about the same time as the European approval of the third anti-TNFα agent (adalimumab) for treating RA patients, the Italian Society of Rheumatology (Società Italiana di Reumatologia [SIR]) started a database for the registration and active follow-up of RA patients treated with biological response modifiers, which contains all of the demographic and clinical parameters, as well as the therapeutic data, usually needed to follow RA patients...http://www.reumatismo.org/index.php/reuma/article/view/403 |
| spellingShingle | R. Caporali M. Filippini R. Gorla E.G. Favalli A. Marchesoni M. Antivalle P. Sarzi- Puttini F. Bobbio-Pallavicini C. Montecucco F. Atzeni Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) Reumatismo |
| title | Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) |
| title_full | Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) |
| title_fullStr | Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) |
| title_full_unstemmed | Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) |
| title_short | Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) |
| title_sort | efficacy and safety of anti tnf agents in the lombardy rheumatoid arthritis network lorhen |
| url | http://www.reumatismo.org/index.php/reuma/article/view/403 |
| work_keys_str_mv | AT rcaporali efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT mfilippini efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT rgorla efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT egfavalli efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT amarchesoni efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT mantivalle efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT psarziputtini efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT fbobbiopallavicini efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT cmontecucco efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen AT fatzeni efficacyandsafetyofantitnfagentsinthelombardyrheumatoidarthritisnetworklorhen |